Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses is a research paper published in Journal for ImmunoTherapy of Cancer (2024). On theSindex it has a DataRank of 0.396. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: F30 CA254168
National Cancer Institute
Grant: P01 CA225517
National Cancer Institute
Grant: P30 CA015704
National Cancer Institute
Grant: T32 CA080416
Kelsey Dickson Team Science Courage Research Award
Grant: N/A
NIH
Grant: S10 OD028685
ASPIRE
Grant: 22-003-AS
National Institutes of Health
Grant: 5F30CA254168-03
Exhaustion mechanisms in Merkel cell polyomavirus-specific T cells
National Institutes of Health
Grant: 5T32CA080416-24
Interdisciplinary Training in Cancer Research
National Institutes of Health
Grant: 5P01CA225517-02
Immunobiology and Immune Therapy for Merkel Cell Carcinoma
National Institutes of Health
Grant: 3P30CA015704-42S2
Cancer Center Support Grant
National Institutes of Health
Grant: 1S10OD028685-01
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases Research
Fields of Study
MeSH Terms
Keywords